dc.contributor.author | Yazilitas, D | |
dc.contributor.author | Sendur, M.A.N | |
dc.contributor.author | Karaca, H | |
dc.contributor.author | Ozdemir, N | |
dc.contributor.author | Aksoy, S | |
dc.contributor.author | Berk, V | |
dc.contributor.author | Yazici, O | |
dc.contributor.author | Oztürk, B | |
dc.contributor.author | Ozkan, M | |
dc.contributor.author | Zengin, N | |
dc.contributor.author | Altundag, K. | |
dc.date.accessioned | 2019-12-10T11:12:15Z | |
dc.date.available | 2019-12-10T11:12:15Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://doi.org/10.7314/APJCP.2015.16.4.1471 | |
dc.identifier.uri | https://www.scopus.com/inward/record.url?eid=2-s2.0-84926138033&partnerID=40&md5=a5e788169030d02b3c85890b4573dc61 | |
dc.identifier.uri | http://hdl.handle.net/11655/15016 | |
dc.relation.isversionof | 10.7314/APJCP.2015.16.4.1471 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Asian Pacific Journal of Cancer Prevention | |
dc.contributor.department | İç Hastalıkları | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 1471 | |
dc.identifier.endpage | 1477 | |
dc.description.index | Scopus | |